This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1MD Barber , JA Ross & KC Fearon (1999) Cancer cachexia. Surg Oncol 8, 133–141.
2M Larkin (1998) Thwarting the dwindling progression of cachexia. Lancet 351, 1336.
3MJ Tisdale (1997) Biology of cachexia. J Natl Cancer Inst 89, 1763–1773.
4G Azhar & JY Wei (2006) Nutrition and cardiac cachexia. Curr Opin Clin Nutr Metab Care 9, 18–23.
6WD Dewys , C Begg , PT Lavin , (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497.
7DP Kotler , AR Tierney , JA Culpepper-Morgan , (1990) Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 14, 454–458.
8SD Anker & R Sharma (2002) The syndrome of cardiac cachexia. Int J Cardiol 85, 51–66.
9MJ Delano & LL Moldawer (2006) The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 21, 68–81.
10M Klaude , K Fredriksson , I Tjader , (2007) Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Colch) 112, 499–506.
12J Büntzel & K Küttner (1995) Value of megestrol acetate in treatment of cachexia in head–neck tumors (article in German). Laryngorhinootologie 74, 504–507.
13J Lees (1999) Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care (Engl) 8, 133–136.
14JA Palesty & SJ Dudrick (2003) What we have learned about cachexia in gastrointestinal cancer. Dig Dis 21, 198–213.
15RT Jagoe & AL Goldberg (2001) What do we really know about the ubiquitin–proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 4, 183–190.
16MD Gomes , SH Lecker , RT Jagoe , (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98, 14440–14445.
17SC Bodine , E Latres , S Baumhueter , (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708.
18CJ Wray , JMV Mammen , DD Hershko , (2003) Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35, 698–705.
19SH Lecker , RT Jagoe , A Gilbert , (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18, 39–51.
20MJM Dehoux , RP van Beneden , L Fernandez-Celemin , (2003) Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 544, 214–217.
22S Di Giovanni , A Molon , A Broccolini , (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55, 195–206.
23R Siddiqui , D Pandya , K Harvey , (2006) Nutrition modulation of cachexia/proteolysis. Nutr Clin Pract 21, 155–161.
26A Inui (2002) Cancer anorexia–cachexia syndrome: current issues in research and management. CA Cancer J Clin 52, 72–91.
27HP Ammon & MA Wahl (1991) Pharmacology of Curcuma longa. Planta Med 57, 1–7.
28J Miquel , A Bernd , JM Sempere , (2002) The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34, 37–46.
29B Joe , M Vijaykumar & BR Lokesh (2004) Biological properties of curcumin – cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44, 97–111.
30A Goel , AB Kunnumakkara & BB Aggarwal (2008) Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol 75, 787–809.
31BB Aggarwal , S Shishodia , Y Takada , (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490–7498.
32S Shishodia , MM Chaturvedi & BB Aggarwal (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31, 243–305.
33NR Jana , P Dikshit , A Goswami , (2004) Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11680–11685.
35B Jin & Y-P Li (2007) Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J Cell Biochem 100, 960–969.
37S Busquets , N Carbo , V Almendro , (2001) Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett 167, 33–38.
39RA Sharma , SA Euden , SL Platton , (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847–6854.
40CD Lao , MTIV Ruffin , D Normolle , (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10.
42TH Marczylo , RD Verschoyle , DN Cooke , (2007) Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60, 171–177.
43AS Whitehouse & MJ Tisdale (2003) Increased expression of the ubiquitin–proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB. Br J Cancer 89, 1116–1122.
46D Cai , JD Frantz , NE Tawa Jr, (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119, 285–298.
48HB Breen & NJ Espat (2004) The ubiquitin–proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr 28, 272–277.
49M Llovera , C Garcia-Martinez , N Agell , (1995) Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 61, 138–141.
50PO Hasselgren (1999) Role of the ubiquitin–proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep 26, 71–76.
51M Llovera , N Carbo , J Lopez-Soriano , (1998) Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 133, 83–87.
52M Llovera , C Garcia-Martinez , N Agell , (1997) TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230, 238–241.
53C Garcia-Martinez , M Llovera , N Agell , (1994) Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-α. Biochem Biophys Res Commun 201, 682–686.
56TN Stitt , D Drujan , BA Clarke , (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14, 395–403.
57M Sandri , C Sandri , A Gilbert , (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412.
58E Latres , AR Amini , AA Amini , (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280, 2737–2744.
59Y-P Li , Y Chen , J John , (2005) TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19, 362–370.
60Y-P Li , SH Lecker , Y Chen , (2003) TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17, 1048–1057.
62V Poylin , MU Fareed , P O'Neal , (2008) The NF-κB inhibitor curcumin blocks sepsis-induced muscle proteolysis. Mediators Inflamm 2008, 317851.
64WJ Durham , S Arbogast , E Gerken , (2006) Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 34, 298–303.
65Y Carter , G Liu , J Yang , (2003) Sublethal hemorrhage induces tolerance in animals exposed to cecal ligation and puncture by altering p38, p44/42, and SAPK/JNK MAP kinase activation. Surg Infect (Larchmt) 4, 17–27.